| Business Summary | | Ampersand
Medical
Corp.
is
focused
on
the
design,
development
and
marketing
of
the
InPath
System
(the
System)
of
products,
which
are
intended
to
detect,
at
the
earliest
possible
stage,
cancer
and
cancer-related
diseases.
The
System
may
be
used
in
a
laboratory,
clinic
or
doctor's
office.
The
Company's
subsidiary,
Samba
Technologies,
Sarl
(Samba),
designs,
develops
and
markets
Web-enabled
software-based
systems
for
image
analysis,
image
capture,
and
image
transmission
and
management
in
clinical
and
industrial
applications.
Samba
also
is
developing
the
software
used
in
the
System.
At
year-end
2000,
all
of
the
Company's
reported
revenue
had
been
from
the
sale
of
Samba
products
and
services.
The
Company
operates
primarily
in
an
industry
segment
involving
medical
devices,
diagnostics
and
supplies.
All
of
the
Company's
operations
during
the
year
ended
December
31,
2000
were
conducted
within
this
segment.
The
Company
expects
to
continue
to
focus
its
operations
on
this
industry
segment. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Ampersand
Medical
Corp.
is
engaged
in
the
design,
development
and
marketing
of
instruments,
disposables,
and
tests
to
provide
Point
of
Care
cancer
screening.
AMPM
also
designs,
develops
and
markets
software
based
systems
to
provide
analysis
of
images
on
microscopic
slides.
For
the
six
months
ended
6/30/01,
revenues
rose
29%
to
$697
thousand.
Net
loss
applicable
to
common
rose
81%
to
$6.9
million.
Results
reflect
the
sales
of
Samba
products,
offset
by
higher
R&D
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Peter Gombrich, 63 Chairman,
CEO of the Corp.. | $310K | Leonard Prange Pres,
CFO, Chief Operating Officer, Sec. | 224K | Michael Nelson Sr.
VP, Engineering | -- | Gregory Sachs Sr.
VP, Regulatory and Clinical Affairs | -- | Susan Keesee, Ph.D. VP,
Molecular Research | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|